Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000570054> ?p ?o ?g. }
- W2000570054 endingPage "429" @default.
- W2000570054 startingPage "422" @default.
- W2000570054 abstract "Activation of the phosphoinositide 3-kinase pathway is commonly observed in human prostate cancer. Loss of function of phosphatase and tensin homolog (PTEN) is associated with the activation of AKT and mammalian target of rapamycin (mTOR) in many cancer cell lines as well as in other model systems. However, activation of mTOR is also dependent of kinases other than AKT. Here, we show that activation of mTOR is not dependent on AKT in a prostate-specific PTEN-deficient mouse model of prostate cancer. Pathway bifurcation of AKT and mTOR was noted in both mouse and human prostate tumors. We demonstrated for the first time that cotargeting mTOR and AKT with ridaforolimus/MK-8669 and M1K-2206, respectively, delivers additive antitumor effects in vivo when compared to single agents. Our preclinical data suggest that the combination of AKT and mTOR inhibitors might be more effective in treating prostate cancer patients than current treatment regimens or either treatment alone." @default.
- W2000570054 created "2016-06-24" @default.
- W2000570054 creator A5012470925 @default.
- W2000570054 creator A5013513429 @default.
- W2000570054 creator A5017739254 @default.
- W2000570054 creator A5029894285 @default.
- W2000570054 creator A5032255588 @default.
- W2000570054 creator A5041189084 @default.
- W2000570054 creator A5045195406 @default.
- W2000570054 creator A5045537846 @default.
- W2000570054 creator A5056573353 @default.
- W2000570054 creator A5073783446 @default.
- W2000570054 creator A5074516218 @default.
- W2000570054 creator A5076746289 @default.
- W2000570054 creator A5077755997 @default.
- W2000570054 creator A5078823930 @default.
- W2000570054 creator A5084929452 @default.
- W2000570054 creator A5085524650 @default.
- W2000570054 creator A5089998052 @default.
- W2000570054 creator A5091497261 @default.
- W2000570054 creator A5091683932 @default.
- W2000570054 date "2012-12-01" @default.
- W2000570054 modified "2023-09-23" @default.
- W2000570054 title "Evidence of mTOR Activation by an AKT-Independent Mechanism Provides Support for the Combined Treatment of PTEN-Deficient Prostate Tumors with mTOR and AKT Inhibitors" @default.
- W2000570054 cites W1489145507 @default.
- W2000570054 cites W1658920532 @default.
- W2000570054 cites W1965572978 @default.
- W2000570054 cites W1977416006 @default.
- W2000570054 cites W1977679887 @default.
- W2000570054 cites W1982479809 @default.
- W2000570054 cites W1986093999 @default.
- W2000570054 cites W1987950628 @default.
- W2000570054 cites W1988609792 @default.
- W2000570054 cites W1991560250 @default.
- W2000570054 cites W2009886463 @default.
- W2000570054 cites W2018704721 @default.
- W2000570054 cites W2025319771 @default.
- W2000570054 cites W2043806397 @default.
- W2000570054 cites W2046234516 @default.
- W2000570054 cites W2065616395 @default.
- W2000570054 cites W2067692539 @default.
- W2000570054 cites W2068345721 @default.
- W2000570054 cites W2072119701 @default.
- W2000570054 cites W2073100248 @default.
- W2000570054 cites W2086400515 @default.
- W2000570054 cites W2096691828 @default.
- W2000570054 cites W2102103107 @default.
- W2000570054 cites W2102148658 @default.
- W2000570054 cites W2102648794 @default.
- W2000570054 cites W2114704791 @default.
- W2000570054 cites W2116622644 @default.
- W2000570054 cites W2124831348 @default.
- W2000570054 cites W2126783165 @default.
- W2000570054 cites W2127782142 @default.
- W2000570054 cites W2143958554 @default.
- W2000570054 cites W2153617345 @default.
- W2000570054 cites W2159750196 @default.
- W2000570054 cites W2161810908 @default.
- W2000570054 cites W2163634266 @default.
- W2000570054 cites W2164521538 @default.
- W2000570054 cites W2164895949 @default.
- W2000570054 cites W2316095838 @default.
- W2000570054 cites W2388163742 @default.
- W2000570054 cites W4238567307 @default.
- W2000570054 doi "https://doi.org/10.1593/tlo.12241" @default.
- W2000570054 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3542838" @default.
- W2000570054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23323157" @default.
- W2000570054 hasPublicationYear "2012" @default.
- W2000570054 type Work @default.
- W2000570054 sameAs 2000570054 @default.
- W2000570054 citedByCount "26" @default.
- W2000570054 countsByYear W20005700542013 @default.
- W2000570054 countsByYear W20005700542014 @default.
- W2000570054 countsByYear W20005700542015 @default.
- W2000570054 countsByYear W20005700542016 @default.
- W2000570054 countsByYear W20005700542017 @default.
- W2000570054 countsByYear W20005700542018 @default.
- W2000570054 countsByYear W20005700542019 @default.
- W2000570054 countsByYear W20005700542020 @default.
- W2000570054 countsByYear W20005700542021 @default.
- W2000570054 countsByYear W20005700542022 @default.
- W2000570054 crossrefType "journal-article" @default.
- W2000570054 hasAuthorship W2000570054A5012470925 @default.
- W2000570054 hasAuthorship W2000570054A5013513429 @default.
- W2000570054 hasAuthorship W2000570054A5017739254 @default.
- W2000570054 hasAuthorship W2000570054A5029894285 @default.
- W2000570054 hasAuthorship W2000570054A5032255588 @default.
- W2000570054 hasAuthorship W2000570054A5041189084 @default.
- W2000570054 hasAuthorship W2000570054A5045195406 @default.
- W2000570054 hasAuthorship W2000570054A5045537846 @default.
- W2000570054 hasAuthorship W2000570054A5056573353 @default.
- W2000570054 hasAuthorship W2000570054A5073783446 @default.
- W2000570054 hasAuthorship W2000570054A5074516218 @default.
- W2000570054 hasAuthorship W2000570054A5076746289 @default.
- W2000570054 hasAuthorship W2000570054A5077755997 @default.
- W2000570054 hasAuthorship W2000570054A5078823930 @default.
- W2000570054 hasAuthorship W2000570054A5084929452 @default.
- W2000570054 hasAuthorship W2000570054A5085524650 @default.